Omvoh 100 mg + 200 mg solution for injection in pre-filled pen
Sponsors
Groupe D'etude Therapeutique Des Affections Inflammatoires Du Tube Digestif, Eli Lilly & Co.
Conditions
Crohn's Diseaseseverely active ulcerative colitis (US) and CD (Crohn’s disease)
Phase 4
Efficacy of MIrikizumab to achieve traNsmural healing in patiENTs with Crohn’s Disease : EMINENT CD
Not yet recruitingCTIS2025-521889-95-00
Target: 110Updated: 2026-02-05
A Study to Evaluate Mirikizumab Concentrations in Breast Milk Following Administration of Mirikizumab by Subcutaneous Injection in Lactating Participants Receiving Mirikizumab Therapeutically for an Approved Indication
Not yet recruitingCTIS2025-522362-78-00
Target: 12Updated: 2026-04-28